Equity
€93,102 ▲ 20.3%
Dr. ELX paid out €35,000 in dividends. That is 69% of the 2025 profit.
Dr. ELX
Lifetime
7 annual accounts with figures on one time axispeak €105,137 (2020)
€67,915▼ 4.5%
peak €78,192 (2020)
€50,700▼ 5.9%
peak €138,545 (2021)
€93,102▲ 20.3%
€11,363▼ 12.1%
Board1 name since 2019
1 director
Documentsfilings and deeds
20-07-202611 days before the deadline
2025micro format
Dividend €35,000Equity from €77,402 to €93,102
Key points
from the 2025 annual accountsTurnover
≈ €150,000 estimated
The micro format states no turnover.
Liquidity
9.25 was 6.62 in 2024
Short-term debts fell from €12,855 to €10,899.
Filings
7 annual accounts since 2019
The last five annual accounts were filed 3 to 11 days before the end of the period.
Starting capital
€18,600 186 shares
Position in the sector
89.1%
Higher solvency than 82% of companies in human health. Sector median 63.1% · 21,322 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as Dr. ELX has now. Each dot stands for 68 companies, two years later.
94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for Dr. ELX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0721497381
Company renamed from DR. to Dr. ELX
Change of role: , from manager to director · Director discharge: · General meeting of 28-12-2023 · Gazette deed
Registered office moved from Alken to Stevoort
New registered office: Lindestraat 98 te 3512 Stevoort · Previous registered office: Ridderstraat 13/4 te 3570 Alken · General meeting of 01-08-2022 · Gazette deed
Registered office moved from Hasselt to Alken
New registered office: Ridderstraat 13/4 te 3570 Alken · Previous registered office: Nieuwe-Winningstraat 28/0003 te 3500 HASSELT · General meeting of 02-11-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. ELX Hasselt | €104,465 | €67,915 | 89.1% | - |
| Dr. Jolien Wevers Haacht | €106,669 | €66,592 | 12.8% | - |
| Huisarts Lien Declerck Lebbeke | €109,209 | €68,087 | 48.3% | - |
| Dokter Hanne Op de Beeck Sint-Katelijne-Waver | €114,542 | €65,438 | 67.0% | - |
| DR. DAPHNE LAPEIRE Bruges | €97,031 | €74,630 | 19.2% | - |
| Dr Ouadi Z. Courcelles | €97,508 | €63,375 | 35.8% | - |
| DR. JOLIEN VAN LOMMEL Kasterlee | €113,765 | €69,459 | 48.3% | - |
These companies have the same main activity as Dr. ELX: general medical practice (NACE 86210). They are comparable in size and age: total assets between €97,000 and €115,000, founded between 2018 and 2020.
Official details
Source: KBO- Status
- Active since 24-02-2019Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.285.933.2763500 Hasselt, since 24-02-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 07-08-2025
Annual accounts 2025
- €104,465▲ 15.7%
- Filing
- Filed on 20-07-2026, 11 days before the end of the filing period
Insights on Dr. ELX
Dr. ELX files the micro format. That format states no turnover. The gross margin rose from €44,315 in 2019 to €67,915 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. ELX
- What is the company number of Dr. ELX?
- The company number of Dr. ELX is 0721.497.381. The VAT number is the same number with BE in front: BE 0721.497.381.
- Where is Dr. ELX based?
- The registered office is at Lindestraat 98, 3512 Hasselt.Company details
- What does Dr. ELX do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Dr. ELX?
- Dr. ELX is a private limited company (BV).
- When was Dr. ELX founded?
- Dr. ELX was founded on 24-02-2019.
- Is Dr. ELX still active?
- Yes, Dr. ELX is an active enterprise in the KBO register.
- What is the turnover of Dr. ELX?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €67,915 and 34 comparable companies (NACE 862). It probably lies between €120,000 and €190,000.Financials
- Is Dr. ELX profitable?
- In financial year 2025, Dr. ELX made a profit of €50,700.
- Where can I find the annual accounts of Dr. ELX?
- Dr. ELX filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. ELX due?
- Dr. ELX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.